Welcome To Cell Medica

Cell Medica is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies.

Our approach combines the highly differentiated, natural biology of a specific subset of cytotoxic T cells, called Natural Killer T cells (NKT cells) and innovative CAR construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.

Latest
News